347 related articles for article (PubMed ID: 36051349)
1. Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review.
Ganguly R; Gupta A; Pandey AK
World J Gastroenterol; 2022 Jul; 28(26):3047-3062. PubMed ID: 36051349
[TBL] [Abstract][Full Text] [Related]
2. Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects.
Hu Q; Zhang W; Wu Z; Tian X; Xiang J; Li L; Li Z; Peng X; Wei S; Ma X; Zhao Y
Pharmacol Res; 2021 Mar; 165():105444. PubMed ID: 33493657
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterisation of baicalin magnesium and its protective effect in ulcerative colitis via gut microbiota-bile acid axis modulation.
Zhang L; Miao C; Wang Z; Guan X; Ma Y; Song J; Shen S; Song H; Li M; Liu C
Phytomedicine; 2024 Apr; 126():155416. PubMed ID: 38394726
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological properties of baicalin on liver diseases: a narrative review.
Yang JY; Li M; Zhang CL; Liu D
Pharmacol Rep; 2021 Oct; 73(5):1230-1239. PubMed ID: 33595821
[TBL] [Abstract][Full Text] [Related]
5. Baicalin Attenuates Alcoholic Liver Injury through Modulation of Hepatic Oxidative Stress, Inflammation and Sonic Hedgehog Pathway in Rats.
Wang H; Zhang Y; Bai R; Wang M; Du S
Cell Physiol Biochem; 2016; 39(3):1129-40. PubMed ID: 27576501
[TBL] [Abstract][Full Text] [Related]
6. Baicalin protects against zearalenone-induced chicks liver and kidney injury by inhibiting expression of oxidative stress, inflammatory cytokines and caspase signaling pathway.
Xu J; Li S; Jiang L; Gao X; Liu W; Zhu X; Huang W; Zhao H; Wei Z; Wang K; Yang Z
Int Immunopharmacol; 2021 Nov; 100():108097. PubMed ID: 34521024
[TBL] [Abstract][Full Text] [Related]
7. Baicalin inhibits PDGF-BB-induced hepatic stellate cell proliferation, apoptosis, invasion, migration and activation via the miR-3595/ACSL4 axis.
Wu X; Zhi F; Lun W; Deng Q; Zhang W
Int J Mol Med; 2018 Apr; 41(4):1992-2002. PubMed ID: 29393361
[TBL] [Abstract][Full Text] [Related]
8. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway.
Chen Q; Liu M; Yu H; Li J; Wang S; Zhang Y; Qiu F; Wang T
J Nat Med; 2018 Jun; 72(3):655-666. PubMed ID: 29542003
[TBL] [Abstract][Full Text] [Related]
9. Baicalin inhibits APEC-induced lung injury by regulating gut microbiota and SCFA production.
Peng LY; Shi HT; Tan YR; Shen SY; Yi PF; Shen HQ; Fu BD
Food Funct; 2021 Dec; 12(24):12621-12633. PubMed ID: 34821232
[TBL] [Abstract][Full Text] [Related]
10. Baicalin and its aglycone: a novel approach for treatment of metabolic disorders.
Fang P; Yu M; Shi M; Bo P; Gu X; Zhang Z
Pharmacol Rep; 2020 Feb; 72(1):13-23. PubMed ID: 32016847
[TBL] [Abstract][Full Text] [Related]
11. Role of Intestinal Microbiota in Baicalin-Induced Drug Interaction and Its Pharmacokinetics.
Noh K; Kang Y; Nepal MR; Jeong KS; Oh DG; Kang MJ; Lee S; Kang W; Jeong HG; Jeong TC
Molecules; 2016 Mar; 21(3):337. PubMed ID: 26978333
[TBL] [Abstract][Full Text] [Related]
12. Baicalin ameliorates experimental inflammatory bowel disease through polarization of macrophages to an M2 phenotype.
Zhu W; Jin Z; Yu J; Liang J; Yang Q; Li F; Shi X; Zhu X; Zhang X
Int Immunopharmacol; 2016 Jun; 35():119-126. PubMed ID: 27039210
[TBL] [Abstract][Full Text] [Related]
13. High doses of baicalin induces kidney injury and fibrosis through regulating TGF-β/Smad signaling pathway.
Cai Y; Ma W; Xiao Y; Wu B; Li X; Liu F; Qiu J; Zhang G
Toxicol Appl Pharmacol; 2017 Oct; 333():1-9. PubMed ID: 28803990
[TBL] [Abstract][Full Text] [Related]
14. Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet.
Guo HX; Liu DH; Ma Y; Liu JF; Wang Y; Du ZY; Wang X; Shen JK; Peng HL
Acta Pharmacol Sin; 2009 Nov; 30(11):1505-12. PubMed ID: 19890358
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of baicalin on allergic response in ovalbumin-induced allergic rhinitis guinea pigs and lipopolysaccharide-stimulated human mast cells.
Zhou YJ; Wang H; Sui HH; Li L; Zhou CL; Huang JJ
Inflamm Res; 2016 Aug; 65(8):603-12. PubMed ID: 27043920
[TBL] [Abstract][Full Text] [Related]
16. Systematic Understanding of the Mechanism of Baicalin against Ischemic Stroke through a Network Pharmacology Approach.
Xu T; Ma C; Fan S; Deng N; Lian Y; Tan L; Du W; Zhang S; Liu S; Ren B; Li Z; Wang Q; Wang X; Cheng F
Evid Based Complement Alternat Med; 2018; 2018():2582843. PubMed ID: 30647760
[TBL] [Abstract][Full Text] [Related]
17. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
18. Baicalin Inhibits Cell Proliferation and Inflammatory Cytokines Induced by Tumor Necrosis Factor α (TNF-α) in Human Immortalized Keratinocytes (HaCaT) Human Keratinocytes by Inhibiting the STAT3/Nuclear Factor kappa B (NF-κB) Signaling Pathway.
Wu X; Deng X; Wang J; Li Q
Med Sci Monit; 2020 Apr; 26():e919392. PubMed ID: 32321906
[TBL] [Abstract][Full Text] [Related]
19. Latest research progress on anticancer effect of baicalin and its aglycone baicalein.
Wang L; Feng T; Su Z; Pi C; Wei Y; Zhao L
Arch Pharm Res; 2022 Aug; 45(8):535-557. PubMed ID: 35908250
[TBL] [Abstract][Full Text] [Related]
20. An overview of pharmacological activities of baicalin and its aglycone baicalein: New insights into molecular mechanisms and signaling pathways.
Hu Z; Guan Y; Hu W; Xu Z; Ishfaq M
Iran J Basic Med Sci; 2022 Jan; 25(1):14-26. PubMed ID: 35656442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
